NIH/DOD New Funding Opportunities for the
Vaccine & Bio-Defense Industry
Special 1x1 Meetings with FreeMind Group at CHI/ImmVacS, August 17-19
The Federal Agencies, mainly NIH and DOD, are moving towards the industry offering a wide range of funding opportunities from early stage research all the way to the later stages of clinical studies and up to Phase III. These alternative funding mechanisms have become of greater interest to both small size start ups and large scale and even big Pharma alike.
FreeMind Group is the leading consulting firm that specializes in raising funds from non-dilutive sources. The enhanced joint process of our 25 full-time analysts and writers supports our clients' needs, from the strategic assessment of the research objectives to writing the applications. Over the past decade we have helped hundreds of companies and academic institutions to secure funding, mainly from the NIH and DOD.
FreeMind's Managing Partner, Mr. Ram May-Ron will hold 1X1 meetings during the CHI ImmVacS conference to discuss these opportunities.
August 17-19, 2010
Royal Sonesta Hotel, Cambridge, MA.